{"id":2356,"date":"2020-05-05T00:00:00","date_gmt":"2020-05-05T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2356"},"modified":"2020-05-05T00:00:00","modified_gmt":"2020-05-05T00:00:00","slug":"centogene-informa-los-resultados-financieros-del-ano-completo-2019-y-destaca-el-progreso-reciente","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/","title":{"rendered":"CENTOGENE informa los resultados financieros del a\u00f1o completo 2019 y destaca el progreso reciente"},"content":{"rendered":"<p>Cambridge, MA, EE. UU. y Rostock, Berl\u00edn, ALEMANIA, 23 de abril de 2020 \u2013 Centogene NV (Nasdaq: CNTG), una empresa en fase comercial centrada en enfermedades raras que transforma datos cl\u00ednicos y gen\u00e9ticos del mundo real en informaci\u00f3n \u00fatil para pacientes, m\u00e9dicos y compa\u00f1\u00edas farmac\u00e9uticas, anunci\u00f3 hoy una actualizaci\u00f3n corporativa e inform\u00f3 sus resultados financieros para el a\u00f1o finalizado el 31 de diciembre de 2019.<\/p>\n<ul>\n<li>48,8 millones de euros en ingresos, un aumento de 21% en comparaci\u00f3n con el a\u00f1o finalizado el 31 de diciembre de 2018, con un crecimiento de aproximadamente 51% en ingresos en el cuarto trimestre finalizado el 31 de diciembre de 2019 en comparaci\u00f3n con el cuarto trimestre finalizado el 31 de diciembre de 2018<\/li>\n<li>28 nuevas colaboraciones farmac\u00e9uticas y 76 colaboraciones activas\/finalizadas en total al 31 de diciembre de 2019 con 39 socios farmac\u00e9uticos que cubren m\u00e1s de 45 enfermedades raras<\/li>\n<li>M\u00e1s de 133.000 solicitudes de pedido recibidas en el a\u00f1o finalizado el 31 de diciembre de 2019, un aumento de m\u00e1s de 27% en comparaci\u00f3n con el a\u00f1o anterior<\/li>\n<li>Expansi\u00f3n continua de la plataforma global de propiedad exclusiva sobre enfermedades raras con m\u00e1s de 2.500 millones de puntos de datos ponderados, de aproximadamente 500.000 pacientes que representan a 120 pa\u00edses diferentes<\/li>\n<li>Recibi\u00f3 la acreditaci\u00f3n del Colegio Americano de Pat\u00f3logos (CAP) para el Biorepositorio en Rostock, Alemania, el primer biorepositorio fuera de los EE. UU. en recibir dicha acreditaci\u00f3n.<\/li>\n<li>En total, 58 programas de biomarcadores, de los cuales 14 biomarcadores que cubren ocho enfermedades raras, han completado su desarrollo.<\/li>\n<\/ul>\n<p>\u201c2019 fue un a\u00f1o crucial en la evoluci\u00f3n de CENTOGENE, durante el cual logramos avances significativos hacia nuestro objetivo de convertirnos en un l\u00edder mundial en el suministro de conocimientos moleculares para acelerar el desarrollo de f\u00e1rmacos para enfermedades raras y guiar la estratificaci\u00f3n, identificaci\u00f3n y monitoreo de pacientes\u201d, afirm\u00f3 el Prof. Arndt Rolfs, CEO de CENTOGENE. Nuestro aumento de 21% en ingresos durante el ejercicio finalizado el 31 de diciembre de 2019 se debi\u00f3 al s\u00f3lido y continuo crecimiento de nuestro segmento farmac\u00e9utico, que cont\u00f3 con nueve nuevos socios y 28 nuevas colaboraciones en las diferentes etapas del desarrollo de f\u00e1rmacos hu\u00e9rfanos, desde el descubrimiento de dianas terap\u00e9uticas hasta la comercializaci\u00f3n. Nos complace especialmente formar una alianza con Pfizer para identificar nuevas dianas terap\u00e9uticas utilizando CentoMD\u00ae y CentoPharma\u00ae, as\u00ed como ampliar nuestra colaboraci\u00f3n con Shire (filial de Takeda Pharmaceutical Company Limited), lo que demuestra a\u00fan m\u00e1s el reconocimiento de la industria farmac\u00e9utica a nuestro conocimiento insuperable en enfermedades raras y el valor de nuestra plataforma global propia para enfermedades raras. El s\u00f3lido rendimiento financiero y operativo de 2019 nos proporciona una base s\u00f3lida para nuestro negocio, y esperamos aprovechar los ingresos de nuestra oferta p\u00fablica inicial en EE. UU. para seguir invirtiendo en \u00e1reas clave de crecimiento.\u201c<\/p>\n<p>El Prof. Rolfs continu\u00f3: \u201cAdem\u00e1s, dada la pandemia de COVID-19, CENTOGENE ha tomado una serie de medidas para proteger a sus empleados y socios comerciales, incluyendo la implementaci\u00f3n de una pol\u00edtica de teletrabajo para la mayor\u00eda de nuestros empleados. Como parte de la iniciativa de la Compa\u00f1\u00eda para ayudar a las autoridades locales, nacionales e internacionales en sus esfuerzos por diagnosticar casos de COVID-19, decidimos aprovechar nuestros amplios conocimientos m\u00e9dicos y equipo t\u00e9cnico para comenzar a realizar pruebas de COVID-19 en marzo de 2020\u201d.\u201d <\/p>\n<p>En abril de 2020, CENTOGENE anunci\u00f3 la apertura de un laboratorio en Hamburgo para aumentar la capacidad de prueba del virus COVID-19, lo que ampliar\u00e1 la capacidad de laboratorio para las pruebas de diagn\u00f3stico de enfermedades gen\u00e9ticas raras de la empresa.<\/p>\n<p>Contacto de CENTOGENE:<br \/> Sun Kim<br \/> Director de Estrategia y Relaciones con Inversores<br \/> <a href=\"mailto:investor.relations@centogene.com\" title=\"Escribe un correo electr\u00f3nico\">relacionesconinversores@centogene.com<\/a>&nbsp;<\/p>\n<p> Contacto de prensa:<br \/> Bridie Lawlor<br \/> Consultor\u00eda FTI<br \/> +1.917.929.5684<br \/> <a href=\"mailto:bridie.lawlor@fticonsulting.com\" title=\"Escribe un correo electr\u00f3nico\">bridie.lawlor(arroba)fticonsulting(punto)com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Cambridge, MA, USA &amp; Rostock, Berlin, GERMANY, April 23, 2020 \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2356","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/centogene-informa-los-resultados-financieros-del-ano-completo-2019-y-destaca-el-progreso-reciente\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"Cambridge, MA, USA &amp; Rostock, Berlin, GERMANY, April 23, 2020 \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/centogene-informa-los-resultados-financieros-del-ano-completo-2019-y-destaca-el-progreso-reciente\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-05T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress\",\"datePublished\":\"2020-05-05T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/\"},\"wordCount\":515,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/\",\"name\":\"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2020-05-05T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE publica sus resultados financieros del ejercicio 2019 y destaca los avances recientes | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/centogene-informa-los-resultados-financieros-del-ano-completo-2019-y-destaca-el-progreso-reciente\/","og_locale":"es_ES","og_type":"article","og_title":"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress | CENTOGENE","og_description":"Cambridge, MA, USA &amp; Rostock, Berlin, GERMANY, April 23, 2020 \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on [&hellip;]","og_url":"https:\/\/www.centogene.com\/es\/centogene-informa-los-resultados-financieros-del-ano-completo-2019-y-destaca-el-progreso-reciente\/","og_site_name":"CENTOGENE","article_published_time":"2020-05-05T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress","datePublished":"2020-05-05T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/"},"wordCount":515,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/","url":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/","name":"CENTOGENE publica sus resultados financieros del ejercicio 2019 y destaca los avances recientes | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2020-05-05T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-reports-financial-results-for-full-year-2019-and-highlights-recent-progress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2356"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2356\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}